In this issue of Blood Advances, Silva et al1 report on the 10-year follow-up data from CALGB 10403, the landmark US Intergroup trial that established a pe

This is "Case 2 - Older patient with Ph+ ALL - TKI, Blinatumomab, and Transplant Decisions" by American Society of Hematology on Vimeo, the home for high quality videos and the people who love them.

A video from Anand Patel, Rafael Madero, and Gregory Roloff (as part of Insights from 2026 EHA Annual Meeting), posted on May 27, 2026.

FDA approves pivekimab sunirine-pvzy for blastic plasmacytoid dendritic cell neoplasm, an ultra-rare hematologic malignancy